Commitments and Contingencies - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Product Liability Contingency [Line Items]
Accounts payable and accrued liabilities	$ 100,000	$ 100,000
Accounts Payable and Accrued Expense Related Party		167,500
Drug Product Testing Agreement Consideration To Be Paid In Stages	60,000	175,000
Operating Leases, Future Minimum Payments Due	303,000
Other Inventory, Gross	559,515	$ 154,667
Drug Supplier Commitments Development	156,250
First Drug [Member]
Product Liability Contingency [Line Items]
Other Inventory, Gross	559,515
Second Drug [Member]
Product Liability Contingency [Line Items]
Other Inventory, Gross	$ 58,000